New Findings from J.E. Castro and Co-Authors Describe Advances in Chronic Lymphocytic Leukemia (Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia)

Source :: Clinical Trials Week. January 12, 2015, 600
Publication Year :: 2015
Abstract: By a News Reporter-Staff News Editor at Clinical Trials Week -- Researchers detail new data in Oncology. According to news reporting out of La Jolla, California, by NewsRx editors, research [...]

Subjects :: Recurrence (Disease) -- Drug therapy
Glucocorticoids -- Dosage and administration
Chronic lymphocytic leukemia -- Drug therapy
Methylprednisolone -- Dosage and administration
Health

Tools